Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature

Published:2023-12 Issue: Volume:72 Page:103586
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Mogica Jan Paredes,Tang Haiming,Liang Yuanxin,Zhong Minghao,Hui Pei,Harigopal Malini,Krishnamurti Uma,Fischbach Neal A.,Zhan Haiying^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference24 articles.

1. Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore;Laas;Br J Cancer,2021

2. Trastuzumab emtansine for residual invasive HER2-positive breast cancer;von Minckwitz;N Engl J Med,2019

3. Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer;van de Ven;Cancer Treat Rev,2011

4. Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes;Mittendorf;Clin Cancer Res,2009

5. Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients;Guarneri;Ann Oncol,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer;European Journal of Cancer;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP